News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|July 1, 2014

(VIDEO) Trophectoderm biopsy

A demonstration of trophectoderm biopsy

A demonstration of trophectoderm biopsy

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

ByDamian Alagia, III, MD, MS, MBA, FACS,

July 20th 2026

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients | Image credit: stock.adobe.com

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients

ByJoshua Fitch, Senior Editor

July 20th 2026

CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data

ByJoshua Fitch, Senior Editor

July 17th 2026

Heather Appelbaum, MD, FACOG, explain multimodal approach to adolescent endometriosis

Heather Appelbaum, MD, FACOG, explains multimodal approach to adolescent endometriosis

ByHeather Appelbaum, MD, FACOG

July 17th 2026

CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

ByJoshua Fitch, Senior Editor

July 16th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

CDC: 15% of US women report drinking alcohol during pregnancy

CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients

CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD